Article Details
Retrieved on: 2021-08-17 17:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lumenis is a portfolio company of Baring Private Equity Asia. Story continues. Stellar M22™ is contraindicated for patients with active infection, viral, ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here